nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Urinary hesitation—Fludarabine—lymphatic system cancer	0.0981	0.0981	CcSEcCtD
Propantheline—Dysphagia—Fludarabine—lymphatic system cancer	0.0253	0.0253	CcSEcCtD
Propantheline—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0222	0.0222	CcSEcCtD
Propantheline—Flushing—Teniposide—lymphatic system cancer	0.0214	0.0214	CcSEcCtD
Propantheline—Confusional state—Teniposide—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Propantheline—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0163	0.0163	CcSEcCtD
Propantheline—Dysphagia—Carmustine—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Propantheline—Tachycardia—Teniposide—lymphatic system cancer	0.016	0.016	CcSEcCtD
Propantheline—Confusional state—Fludarabine—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Propantheline—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Propantheline—Erectile dysfunction—Vincristine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Propantheline—Vomiting—Mechlorethamine—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Propantheline—Rash—Mechlorethamine—lymphatic system cancer	0.014	0.014	CcSEcCtD
Propantheline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.014	0.014	CcSEcCtD
Propantheline—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Propantheline—Flushing—Bleomycin—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Propantheline—Feeling abnormal—Teniposide—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Propantheline—Drowsiness—Mitoxantrone—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Propantheline—Nausea—Mechlorethamine—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Propantheline—Urticaria—Teniposide—lymphatic system cancer	0.013	0.013	CcSEcCtD
Propantheline—Constipation—Fludarabine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Propantheline—Hypersensitivity—Teniposide—lymphatic system cancer	0.012	0.012	CcSEcCtD
Propantheline—Flushing—Carmustine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Propantheline—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Propantheline—Asthenia—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Propantheline—Confusional state—Bleomycin—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Propantheline—Vision blurred—Carmustine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Propantheline—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Propantheline—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Propantheline—Vomiting—Teniposide—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Propantheline—Asthenia—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Propantheline—Rash—Teniposide—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Propantheline—Dermatitis—Teniposide—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Propantheline—Headache—Teniposide—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Propantheline—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00987	0.00987	CcSEcCtD
Propantheline—Nausea—Teniposide—lymphatic system cancer	0.00971	0.00971	CcSEcCtD
Propantheline—Confusional state—Carmustine—lymphatic system cancer	0.00927	0.00927	CcSEcCtD
Propantheline—Vomiting—Fludarabine—lymphatic system cancer	0.00913	0.00913	CcSEcCtD
Propantheline—Rash—Fludarabine—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Propantheline—Dermatitis—Fludarabine—lymphatic system cancer	0.00905	0.00905	CcSEcCtD
Propantheline—Headache—Fludarabine—lymphatic system cancer	0.009	0.009	CcSEcCtD
Propantheline—Tachycardia—Carmustine—lymphatic system cancer	0.00897	0.00897	CcSEcCtD
Propantheline—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00878	0.00878	CcSEcCtD
Propantheline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00868	0.00868	CcSEcCtD
Propantheline—Confusional state—Mitoxantrone—lymphatic system cancer	0.00862	0.00862	CcSEcCtD
Propantheline—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00855	0.00855	CcSEcCtD
Propantheline—Nausea—Fludarabine—lymphatic system cancer	0.00853	0.00853	CcSEcCtD
Propantheline—Urticaria—Bleomycin—lymphatic system cancer	0.00837	0.00837	CcSEcCtD
Propantheline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00834	0.00834	CcSEcCtD
Propantheline—Insomnia—Carmustine—lymphatic system cancer	0.00832	0.00832	CcSEcCtD
Propantheline—Somnolence—Carmustine—lymphatic system cancer	0.00817	0.00817	CcSEcCtD
Propantheline—Insomnia—Vincristine—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Propantheline—Constipation—Carmustine—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Propantheline—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Propantheline—Somnolence—Mitoxantrone—lymphatic system cancer	0.0076	0.0076	CcSEcCtD
Propantheline—Feeling abnormal—Carmustine—lymphatic system cancer	0.00758	0.00758	CcSEcCtD
Propantheline—Asthenia—Bleomycin—lymphatic system cancer	0.00756	0.00756	CcSEcCtD
Propantheline—Constipation—Vincristine—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Propantheline—Constipation—Mitoxantrone—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Propantheline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00704	0.00704	CcSEcCtD
Propantheline—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Propantheline—Urticaria—Mitoxantrone—lymphatic system cancer	0.00679	0.00679	CcSEcCtD
Propantheline—Hypersensitivity—Carmustine—lymphatic system cancer	0.00677	0.00677	CcSEcCtD
Propantheline—Vomiting—Bleomycin—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Propantheline—Drowsiness—Methotrexate—lymphatic system cancer	0.00668	0.00668	CcSEcCtD
Propantheline—Rash—Bleomycin—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Propantheline—Dermatitis—Bleomycin—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Propantheline—Asthenia—Carmustine—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Propantheline—Hypersensitivity—Vincristine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Propantheline—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Propantheline—Asthenia—Vincristine—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Propantheline—Nausea—Bleomycin—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Propantheline—Asthenia—Mitoxantrone—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Propantheline—Dizziness—Carmustine—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Propantheline—Vomiting—Carmustine—lymphatic system cancer	0.00585	0.00585	CcSEcCtD
Propantheline—Dizziness—Vincristine—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Propantheline—Rash—Carmustine—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Propantheline—Dermatitis—Carmustine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Propantheline—Headache—Carmustine—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Propantheline—Vomiting—Vincristine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Propantheline—Rash—Vincristine—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Propantheline—Dermatitis—Vincristine—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Propantheline—Headache—Vincristine—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Propantheline—Nausea—Carmustine—lymphatic system cancer	0.00546	0.00546	CcSEcCtD
Propantheline—Vomiting—Mitoxantrone—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Propantheline—Rash—Mitoxantrone—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Propantheline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Propantheline—Headache—Mitoxantrone—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Propantheline—Nausea—Vincristine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Propantheline—Nausea—Mitoxantrone—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Propantheline—Vision blurred—Methotrexate—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Propantheline—Confusional state—Methotrexate—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Propantheline—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Propantheline—Insomnia—Methotrexate—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Propantheline—Somnolence—Methotrexate—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Propantheline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Propantheline—Urticaria—Methotrexate—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Propantheline—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Propantheline—Asthenia—Methotrexate—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Propantheline—Dizziness—Methotrexate—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Propantheline—Vomiting—Methotrexate—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Propantheline—Rash—Methotrexate—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Propantheline—Dermatitis—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Propantheline—Headache—Methotrexate—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Propantheline—Nausea—Methotrexate—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
